Henry I. Miller

Robert Wesson Fellow in Scientific Philosophy and Public Policy
Biography: 

Henry I. Miller, MS, MD, is the Robert Wesson Fellow in Scientific Philosophy and Public Policy at the Hoover Institution. His research focuses on public policy toward science and technology, encompassing a number of areas, including pharmaceutical development, genetic engineering in agriculture, models for regulatory reform, and the emergence of new viral diseases.

Miller served for fifteen years at the US Food and Drug Administration (FDA) in a number of posts. He was the medical reviewer for the first genetically engineered drugs to be evaluated by the FDA and thus instrumental in the rapid licensing of human insulin and human growth hormone. Thereafter, he was a special assistant to the FDA commissioner and the founding director of the FDA's Office of Biotechnology. During his government service, Miller participated frequently on various expert and policy panels as a representative of the FDA or the US government. As a government official, Miller received numerous awards and citations.

Since coming to the Hoover Institution, Miller has become well known not only for his contributions to scholarly journals but also for his articles and books that make science, medicine, and technology accessible. His work has been widely published in many languages. Monographs include Policy Controversy in Biotechnology: An Insider's View; To America's Health: A Model for Reform of the Food and Drug Administration; and The Frankenfood Myth: How Protest and Politics Threaten the Biotech Revolution. Barron's selected The Frankenfood Myth as one of the 25 Best Books of 2004. In addition, Miller has published extensively in a wide spectrum of scholarly journals and popular publications worldwide, including The Lancet, Journal of the American Medical Association, Science, the Nature family of journals, Chronicle of Higher Education, Forbes, National Review, Wall Street Journal, New York Times, the Guardian, Defining Ideas, and the Financial Times. He is a regulator contributor to Forbes.com and frequently appears on the nationally syndicated radio programs of John Batchelor and Lars Larson.

Miller was selected by the editors of Nature Biotechnology as one of the people who had made the "most significant contributions" to biotechnology during the previous decade. He serves on numerous editorial boards.

Filter By:

Topic

Type

Recent Commentary

Analysis and Commentary

How Russia And NGOs Collude To Damage American Exceptionalism

by Henry I. Miller, Jon Entinevia The Daily Caller
Thursday, July 19, 2018

Modern genetic engineering techniques applied to agriculture are making stunning advances. This year, after decades in (gratuitous) regulatory limbo, the U.S. Food and Drug Administration, Health Canada and Food Standards Australia New Zealand gave the green light to domestic import and consumption of Golden Rice, which has been genetically modified to produce provitamin-A.

Blank Section (Placeholder)Featured

Regulatory Dark Matter

by Henry I. Miller, John Cohrssenvia Defining Ideas
Thursday, July 19, 2018

Executive branch agencies like the FDA are abusing their power by issuing excessive rules and guidelines.

Analysis and Commentary

The Mystery Of The ‘Rogue Wheat’

by Henry I. Miller, Robert Wagervia Daily Caller
Thursday, July 12, 2018

The headline read: “How did GMO wheat end up in an Alberta field?” How indeed? (We have a theory.) In the summer of 2017, a contractor applied the popular weed-killer glyphosate (brand name Roundup®) to clear some weeds along an oil and gas service road. (Glyphosate is a very effective herbicide that controls hundreds of different weeds.) When wheat plants did not die after the contractor applied the herbicide, he contacted the authorities.

Analysis and Commentary

USDA Moves To End Rent-Seeking In Poultry Industry

by Henry I. Miller, Jeff Stiervia American Greatness
Wednesday, July 11, 2018

The U.S. Department of Agriculture in December ruffled a few feathers by withdrawing a regulation published on the final full day of the Obama Administration that would have created new requirements for producers of “organic” eggs and poultry.

Blank Section (Placeholder)

“Moon Shot” for the Flu Shot

by Henry I. Millervia Hoover Digest
Monday, July 9, 2018

Americans just endured another flu season—a rough one—and the next is always just a sneeze away. Let’s get serious about improving vaccines and conquering the wily influenza virus.

Blank Section (Placeholder)

Flow West

by Terry Anderson, Henry I. Millervia Hoover Digest
Monday, July 9, 2018

A brisk trade in water rights would send supplies where they’re most needed.

Analysis and Commentary

Scott Pruitt's EPA Policies Reined In A Rogue Agency And Were Good For America -- We Need Them To Continue

by Henry I. Millervia Fox News
Sunday, July 8, 2018

Scott Pruitt, who lost his job as head of the Environmental Protection Agency last week after a flood of complaints and investigations regarding his conduct and ethics, nevertheless accomplished a great deal to institute needed reforms at the agency and roll back harmful and counterproductive over-regulation.

Analysis and Commentary

Russia Does Far Worse Than Meddle In Our Elections — It Meddles In Our Science: Part II

by Henry I. Millervia Investors Business Daily
Thursday, June 28, 2018

In Part 1, I described the vendetta by the Russian government's propaganda apparatus against technologies like fracking and modern genetic engineering techniques applied to agriculture, and the aid the Russians receive from U.S.-based organic industry lobbyists and activists.

Analysis and Commentary

Russia Does Far Worse Than Meddle In Our Elections — It Meddles In Our Science

by Henry I. Millervia Investors Business Daily
Tuesday, June 26, 2018

It's no secret that although the Internet has vastly improved our lives in many respects, it has downsides — less interpersonal interaction, more anonymous snarkiness, online harassment and even cyber-stalking. But arguably worst of all is the amount of purposeful disinformation — fake news — that is promulgated by special interests.

Analysis and Commentary

The FDA: Challenges For A New Century, A Rough Road Ahead For Would-Be Reformers

by Henry I. Millervia New York University Journal Of Law & Liberty
Friday, June 22, 2018
Most Americans don’t think a lot about the scope, magnitude, and impacts of regulation on their lives. The FDA alone, for example, regulates products that account for more than a trillion dollars annually—25 cents of every consumer dollar, and the average cost (including out of pocket expenses and opportunity costs) to bring a new drug to market is now about $2.6 billion.

Pages